Research at NHGRI
The Division of Intramural Research conducts a broad program of laboratory and clinical research.

One little fish hooks genome researchers with its versatility

Read moreModern molecular biology and the genome of a tiny silver and black striped fish - the zebrafish - are making waves in genomics research. This tiny fish is a powerhouse tool that helps researchers better understand the genes that are implicated in disease. Here, at the National Human Genome Research Institute (NHGRI), researchers are working to advance human health by coupling the potential of this little fish with an institute-funded resource known as The Zebrafish Core. Read more

New NIH studies seek adults and families affected by sickle cell disease/trait

Read more People with sickle cell disease (SCD) can experience excruciating pain all over their bodies, kidney problems, higher risk of stroke and in rare cases, chronic leg ulcers. Little is known about why the severity of these symptoms varies throughout the course of a lifetime, and why these symptoms differ from person to person. Researchers at the National Human Genome Research Institute (NHGRI) are seeking help from people affected by SCD. Read more

See all News Features from the Division of Intramural Research


Researchers advance treatment possibilities for Gaucher, Parkinson's

National Institutes of Health researchershave identified and tested a molecule that shows promise as a possible treatment for the rare Gaucher disease and the more common Parkinson's disease. These findings demonstrate how insights from a rare disorder can have direct relevance to the treatment of more common disorders. The findings were published July 12, 2016 in The Journal of Neuroscience. Read more 

A Quarter Century after the Human Genome Project's launch presents: Dr. David Bentley

David BentleyThe NHGRI History of Genomics Program closed its six-part seminar series featuring Human Genome Project (HGP) participants who helped launch the HGP with the talk: The Genome is for Life, by David Bentley, D.Phil., on Thursday, May 26th. Dr. Bentley is vice president and chief scientist at Illumina Inc. His long-term research interest is the study of human sequence variation and its impact on health and disease.  Read more about the series | Read about Dr. Bentley

Last Updated: July 12, 2016